AFM
Anson Funds Management’s Spero Therapeutics SPRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.68M | Sell |
1,615,469
-2,183,463
| -57% | -$6.33M | 0.67% | 25 |
|
|
2025
Q1 | $2.74M | Sell |
3,798,932
-40,954
| -1% | -$29.5K | 0.5% | 33 |
|
|
2024
Q4 | $3.96M | Buy |
3,839,886
+89,436
| +2% | +$92.1K | 0.4% | 27 |
|
|
2024
Q3 | $5.03M | Hold |
3,750,450
| – | – | 0.5% | 18 |
|
|
2024
Q2 | $4.88M | Hold |
3,750,450
| – | – | 0.58% | 16 |
|
|
2024
Q1 | $6.45M | Sell |
3,750,450
-547,249
| -13% | -$941K | 0.42% | 22 |
|
|
2023
Q4 | $6.32M | Buy |
4,297,699
+138,127
| +3% | +$203K | 0.78% | 17 |
|
|
2023
Q3 | $5.03M | Buy |
4,159,572
+714,710
| +21% | +$865K | 1.01% | 12 |
|
|
2023
Q2 | $5M | Buy |
3,444,862
+100,000
| +3% | +$145K | 0.83% | 17 |
|
|
2023
Q1 | $4.85M | Buy |
3,344,862
+325,254
| +11% | +$472K | 0.79% | 21 |
|
|
2022
Q4 | $5.22M | Buy |
3,019,608
+1,545,736
| +105% | +$2.67M | 0.86% | 21 |
|
|
2022
Q3 | $2.95M | Buy |
+1,473,872
| New | +$2.95M | 0.35% | 58 |
|